Back

Gaps Between Willingness and Uptake of Influenza and COVID-19 Vaccines During the 2025-26 Respiratory Virus Season in a U.S. Adult Cohort

Sanborn, J.; Robertson, M.; Penrose, K.; Rane, M. S.; Piltch-Loeb, R.; Parcesepe, A.; Nash, D.

2026-07-19 epidemiology
10.64898/2026.07.17.26358235 medRxiv
Show abstract

During the 2025-26 respiratory virus season, changes to COVID-19 vaccine eligibility, recommendations, and communication may have made vaccination follow-through especially challenging. Under-vaccination may reflect not only lack of willingness, but also breakdowns between willingness and uptake. We analyzed data from 3,390 adults in the CHASING COVID Cohort who completed assessments in August 2025 and March 2026 to examine gaps between vaccine willingness and subsequent influenza and COVID-19 vaccination. Vaccine willingness was defined using prior-season vaccination and stated intention to vaccinate during the 2025-26 respiratory virus season. In August 2025, 73% of participants were influenza vaccine willing and 68% were COVID-19 vaccine willing. Among vaccine-willing participants, 17% and 39% were unvaccinated for influenza and COVID-19, respectively, by March 2026. Absence of prior-season vaccination was the strongest predictor of not vaccinating for influenza and COVID-19, respectively (aRR [95% CI]: 4.04 [3.44-4.74]; 3.01 [2.72-3.34]). Non-vaccination was also associated with food insecurity (1.99 [1.66-2.37]; 1.47 [1.33-1.63]), any healthcare barrier (1.89 [1.57-2.28]; 1.51 [1.36-1.67]), and being not at all confident in vaccine safety (2.95 [2.15-4.05]; 2.21 [1.88-2.59]). Trajectory analyses suggested willingness-uptake gaps reflected incomplete follow-through on intentions and discontinuation among some prior vaccinators. Commonly reported reasons among vaccine-willing non-vaccinators included difficulty finding a convenient time, place, or appointment and, for COVID-19, lack of healthcare provider recommendation. Findings among non-vaccinated adults with prior or stated openness to vaccinate highlight missed opportunities and suggest avenues to improve coverage through strategies that reinforce vaccine confidence, reduce access and logistical barriers, and make vaccination easier to complete.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Vaccine
203 papers in training set
Top 0.1%
40.2%
2
Influenza and Other Respiratory Viruses
46 papers in training set
Top 0.1%
13.1%
50% of probability mass above
3
PLOS ONE
5266 papers in training set
Top 28%
5.6%
4
Vaccine: X
22 papers in training set
Top 0.2%
3.2%
5
PLOS Global Public Health
344 papers in training set
Top 4%
3.2%
6
American Journal of Epidemiology
67 papers in training set
Top 0.5%
2.5%
7
Vaccines
198 papers in training set
Top 1%
2.4%
8
BMC Public Health
158 papers in training set
Top 3%
2.0%
9
The Lancet Regional Health - Americas
22 papers in training set
Top 0.2%
1.8%
10
Open Forum Infectious Diseases
142 papers in training set
Top 2%
1.8%
11
BMJ Open
601 papers in training set
Top 9%
1.7%
12
Clinical Infectious Diseases
235 papers in training set
Top 2%
1.1%
13
Epidemics
116 papers in training set
Top 1%
1.1%
14
Preventive Medicine Reports
15 papers in training set
Top 0.3%
1.1%
15
BMC Infectious Diseases
133 papers in training set
Top 4%
1.1%
16
JAMA Network Open
130 papers in training set
Top 3%
1.1%
17
Eurosurveillance
83 papers in training set
Top 0.9%
0.9%
18
American Journal of Preventive Medicine
11 papers in training set
Top 0.3%
0.9%
19
Nature Communications
5641 papers in training set
Top 56%
0.9%
20
The Journal of Infectious Diseases
202 papers in training set
Top 4%
0.9%
21
BMC Medicine
176 papers in training set
Top 5%
0.9%
22
The Lancet Regional Health - Europe
33 papers in training set
Top 0.6%
0.6%
23
Human Vaccines & Immunotherapeutics
25 papers in training set
Top 0.6%
0.6%
24
PLOS Medicine
110 papers in training set
Top 4%
0.6%